Automated Cell Shakers Market to Reach USD 920.8 Million by 2035, Growing at 3.5% CAGR Analysis by Future Market Insight

Future Market Insights (FMI), a leading provider of market intelligence and consulting services, today announced the publication of its latest comprehensive report, "Automated Cell Shakers Market Size & Growth 2025 to 2035." Despite some challenges, the market is likely to reach USD 920.8 million by 2035, at a CAGR of 3.5%, with strong investments in automated bioprocessing solutions, AI-powered laboratory equipment, and next-gen cell culture automation technologies. The report highlights the transformative role of AI-powered equipment, IoT integration, and smart shaking platforms in enhancing reproducibility and efficiency across pharmaceutical research, regenerative medicine, and biotechnology sectors. This growth underscores the market's critical impact on accelerating drug discovery and biologics manufacturing, addressing global healthcare challenges in an era of personalized medicine.

Automated Cell Shakers Market Insights: Trends, Drivers, Challenges, Opportunities, and Competitive Landscape:

The automated cell shakers market is poised for consistent growth, fueled by a confluence of technological innovations and increasing applications in life sciences. Key trends identified in the report include the integration of AI and IoT for real-time monitoring of parameters like pH, dissolved oxygen, and metabolites, enabling dynamic optimization of shaking conditions. Cloud-connected systems are emerging as a game-changer, allowing remote control and data analytics to improve laboratory workflows. Additionally, the shift toward energy-efficient, low-noise designs aligns with sustainability goals, such as recyclable components and reduced resource wastage.

Growth drivers are multifaceted. The surging demand for high-throughput screening (HTS) in drug discovery, coupled with expansions in cell-based therapies, vaccines, and biologics, is a primary catalyst. Biopharmaceutical industries are increasingly adopting automated shakers to ensure uniform cell growth and nutrient distribution, particularly in orbital and incubator models. Investments in regenerative medicine and stem cell research further propel the market, as these applications require precise temperature, CO₂, and humidity control for optimal cell viability. Regionally, emerging markets in Asia-Pacific, such as India and China, are witnessing accelerated adoption due to government-backed biotech initiatives and collaborations between academia and industry.

Automated Cell Shakers Market Update: Latest Developments Shaping the Market:

The automated cell shakers sector has seen significant momentum in recent months, reflecting broader trends in laboratory automation and bioprocessing. In August 2025, just 12 weeks prior to this report's analysis period, U.S.-based robotics and automation startups secured a record USD 748.9 million in venture funding, signaling strong investor confidence in technologies that underpin automated shakers, such as AI-driven predictive maintenance and smart bioreactors. This influx is expected to accelerate product innovations, reducing downtime and improving supply chain resilience amid ongoing global disruptions.

Earlier in the year, the U.S. Department of Commerce awarded USD 50 million to HP Inc. to advance semiconductor technologies critical for life sciences instrumentation, including automated cell shakers. This grant highlights governmental commitment to bolstering domestic manufacturing of high-precision lab equipment, potentially easing regulatory hurdles and fostering energy-efficient designs compliant with ENERGY STAR and EU EcoDesign directives.

On the partnership front, collaborations between academia and biopharma giants are proliferating. For instance, in mid-2025, Thermo Fisher Scientific teamed up with leading regenerative medicine institutes to develop next-generation shaking systems with enhanced control features and IoT connectivity, aimed at stem cell expansion and personalized therapies. Similarly, Eppendorf AG expanded its portfolio through acquisitions in the smart lab space, integrating cloud-based monitoring into its incubator shakers. Regulatory updates have also influenced the landscape: The FDA and EMA have tightened standards on AI-driven bioprocess automation, emphasizing real-time cell growth monitoring and standardization for global labs, which could streamline compliance but increase validation costs.

Automated Cell Shakers Market Applications: Unlocking Value Across Sectors:

The insights from FMI's report offer actionable benefits for a wide array of industries and businesses. In the pharmaceutical and biopharmaceutical sectors, automated cell shakers enhance drug development by providing reproducible conditions for HTS and protein expression, reducing human error and accelerating time-to-market for biologics and vaccines. Companies like mega pharmaceutical firms and contract development and manufacturing organizations (CDMOs/CMOs) can leverage AI-optimized shakers to scale production while complying with GMP and FDA standards, ultimately lowering costs and improving yield.

Biotechnology and regenerative medicine enterprises stand to gain from advanced incubator shakers that support stem cell research and cell therapy applications. By enabling precise control over somatic and infinite cell lines, these systems facilitate breakthroughs in personalized medicine, such as gene therapies using HEK293 or CHO cells. Academic institutes and research organizations can utilize benchtop models for cost-effective, space-efficient setups, fostering innovation in cancer studies and toxicological testing.

Key Players in the Automated Cell Shakers Market:

The report profiles leading companies shaping the industry:

• Thermo Fisher Scientific: A dominant force with precision-engineered shakers for cell culture research.
• Eppendorf AG: Offers scalable platforms with digital controls for reproducible results.
• Benchmark Scientific: Focuses on compact, high-performance solutions for biotech labs.
• Ohaus Corporation: Provides durable, energy-efficient orbital shakers for microbiology and drug development.
• Grant Instruments: Specializes in vibration-free incubated shakers for academic and pharmaceutical applications.

Other notable players include Kuhner Shaker, Infors AG, Esco Micro Pte. Ltd., Corning Incorporated, Labtron Equipment Ltd., Danaher Corporation, LabStrong, Bio-Rad Laboratories, Merck KGaA, Sartorius AG, Hamilton Medical AG, Miltenyi Biotec, Heidolph Instruments GmbH & CO. KG, Inheco Industrial Heating & Cooling GmbH, SIA Biosan, BIOBASE GROUP, Boekel Scientific, Eberbach, and OPTIMA Inc.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/checkout/18542

Request for Discount: https://www.futuremarketinsights.com/reports/sample/rep-gb-18542

Automated Cell Shakers Recent Developments in the Market:

Building on the industry's momentum, recent highlights include Thermo Fisher Scientific's launch of an AI-enhanced orbital shaker series in Q3 2025, featuring adaptive speed optimization for diverse cell lines. Eppendorf AG announced a strategic partnership with a European biotech consortium in September 2025 to co-develop cloud-integrated systems, targeting regenerative therapy applications. In October 2025, Benchmark Scientific introduced energy-efficient models compliant with new EU EcoDesign regulations, addressing sustainability demands.

Additionally, global investments continue to flow: A USD 200 million funding round for Asian lab automation startups in late 2025 emphasizes IoT-enabled shakers for emerging markets. Regulatory advancements, such as the FDA's updated guidelines on automated bioprocessing in July 2025, have prompted recalls of non-compliant models but opened doors for validated innovations. These developments reinforce the market's trajectory toward smarter, more efficient laboratory ecosystems.

 Explore More Related Studies Published by FMI Research:

Hepatic Encephalopathy Treatment Market: Valued at USD 1.68 billion in 2025, set to reach USD 3.16 billion by 2035 with a CAGR of 6.84%.

Optic Neuropathy Management Market: Estimated at USD 4.74 billion in 2025, anticipated to reach USD 7.72 billion by 2035, growing at 5.0% CAGR.

Vascular Dementia Treatment Market: Valued at USD 6.19 billion in 2025, projected to hit USD 9.87 billion by 2035 at a CAGR of 4.7%.

European Hospital Capacity Management Solutions Market: Set to rise from USD 376.8 million in 2025 to USD 574.1 million by 2035, growing at 4.3% CAGR.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:    

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube